Marina Vaysburd
- Virology top 5%
- HIV Research and Treatment 3
- Immunology top 5%
- interferon and immune responses 10
- Immunotherapy and Immune Responses 4
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 3
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms 4
-
- Virus-based gene therapy research 4
-
- Alzheimer's disease research and treatments 4
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Leo C. JamesWilliam A. McEwanRuth WatkinsonDean CliftJerry C H TamAdam J. FletcherJan Terje AndersenStian Foss
- Partner nations
- United KingdomUnited StatesNorway
In The Last Decade
Marina Vaysburd
29 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 88
- Virology 123
- Immunology 499
- Infectious Diseases 257
- Neurology 80
- Molecular Biology 462
Countries citing papers authored by Marina Vaysburd
This map shows the geographic impact of Marina Vaysburd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Vaysburd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Vaysburd more than expected).
Fields of papers citing papers by Marina Vaysburd
This network shows the impact of papers produced by Marina Vaysburd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Vaysburd. The network helps show where Marina Vaysburd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marina Vaysburd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 23 | |
| 2 | 2024 | 25 | |
| 3 | 2023 | 14 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 19 | |
| 6 | 2022 | 31 | |
| 7 | 2021 | 22 | |
| 8 | 2021 | 16 | |
| 9 | 2021 | 68 | |
| 10 | 2021 | 18 | |
| 11 | 2020 | 58 | |
| 12 | 2019 | 52 | |
| 13 | 2019 | 64 | |
| 14 | 2018 | 46 | |
| 15 | 2018 | 76 | |
| 16 | 2017 | 134 | |
| 17 | 2015 | 32 | |
| 18 | 2013 | 35 | |
| 19 | 2013 | 83 | |
| 20 | 2008 | 12 |
About Marina Vaysburd
Marina Vaysburd is a scholar working on Immunology, Virology and Neurology, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include interferon and immune responses (10 papers), Virus-based gene therapy research (4 papers), Alzheimer's disease research and treatments (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and HIV Research and Treatment (3 papers). The work is most often cited by research in Virology (123 citations), Immunology (499 citations) and Infectious Diseases (257 citations). Marina Vaysburd has collaborated with scholars based in United Kingdom, United States and Norway. Frequent co-authors include Leo C. James, William A. McEwan, Ruth Watkinson, Dean Clift, Jerry C H Tam, Adam J. Fletcher, Jan Terje Andersen, Stian Foss, Kevin O‘Connell and Jingwei Zeng. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.